Clinical trialNCT00875238CompletedObservational

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

SponsorVanderbilt UniversityEnrollment133Breast CancerCardiac ToxicityCardiovascular Complications

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Carrie G Lenneman, MD, MSCI
Vanderbilt-Ingram Cancer Center & Univ. of Louisville
Principal Investigator
clinicaltrials.gov ↗
Daniel Lenihan, MD
Vanderbilt University
Principal Investigator
clinicaltrials.gov ↗
Douglas B Sawyer, MD, PhD
Vanderbilt University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Louisville James Graham Brown Cancer Center
Louisville, Kentucky, United States
Mbccop - Meharry Medical College - Nashville
Nashville, Tennessee, United States
Vanderbilt Heart One Hundred Oaks
Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2008
Primary completion: 31 Mar 2015
Completion: 31 Mar 2015
Last update posted: 19 Feb 2018
Registered enrollment: 133
Registry id: NCT00875238

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.